Domestic sales to drive demand in next three to five years: UBM India survey
The main risk factor recognised by the international respondents is the over-dependence on Chinese sourced APIs, particularly in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Baxter to buy Claris Lifesciences’ global generic injectables business
The $ 625 mn deal is a move to boost Baxter’s presence in this space
Sun Pharma completes acquisition of Ocular Technologies Sarl
In October this year, Sun Pharma announced acquisition for a front payment of $40 million
Cipla’s Netherlands arm to form JV with Iranian distributor Ahran Tejarat Company
The 16.8 m euro JV proposes to undertake manufacturing and marketing of pharmaceutical products in Iran
Drug companies bet on global M&As in growth pursuit: Moody’s
The report also mentioned that M&As can also enhance the expertise of Indian pharma companies in sophisticated and high-entry…
Lupin receives US FDA approval for generic Topicort ointment
The ointment is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
AstraZeneca wins Corporate CSR Best Practices Award at NHRD National Conference
Is also a finalist in the HR Best Practices category for its focus on gender diversity
Sun Pharma, Moebius Medical in global licensing deal
To develop novel liposomal non-opiod pain product for osteoarthritis
Natco Pharma launches Tamiflu generic capsules in US
The company's capsules are generic versions of Roches Tamiflu drug
Strides Shasun to acquire Perrigo’s US FDA approved API facility in India
Strides Shasun will acquire 100 per cent of the issued capital of Perrigo API India for a consideration of Rs 1000 million